The Latvian Medicines Verification Organization (LZVO) informs that on May 5, the new Latvian Medicines Verification System (LZVS) release - version 8.0 - was successfully deployed in the production environment. The system is operating stably, and no technical issues have been identified.
As previously reported, the new LZVS release mainly includes technical updates that do not affect end users of the LZVS. The infrastructure improvements - including security enhancements - are intended to ensure continued system stability and optimal performance for system users.
The updated version 8.0 includes the following infrastructure improvements:
- improvements in the NCA reporting system,
- technical changes to enhance system performance and operation,
- security improvements,
- correction of previously identified minor issues.
The interface version v5 will remain available for end-user connections.
LZVO once again invites IT providers who ensure connections for LZVS end users to begin transitioning to the new connection addresses as soon as possible, thereby enabling faster processing of verification requests and improving system performance.
For any questions, please contact info@lzvo.lv